CYAD | Celyad SA![]()
Quick infos
Trade prices
Next ER: May 5, 2023 Before Market OpensCompany ProfileCelyad focuses on translating promising research into transformative treatments aimed at reversing the outcome of severe diseases. Celyad identifies and further advances therapeutic solutions that have the potential to change the lives of thousands of patients worldwide. Earnings History
NASDAQ - Nasdaq Stock Market More profiles and info about the company
NewsNews for (CYAD)
This company doesn't provide a dividend. Key Persons
Talk about Celyad SA below in comments section below.Do you think you'll buy? Do you already have active trades now? EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. | NotesResearchInvestor pagewww.celyad.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books![]() Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written. |